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Abstract
Background: Neutrophils have been shown to play a role in host defence against highly virulent
and mouse-adapted strains of influenza virus, however it is not clear if an effective neutrophil
response is an important factor moderating disease severity during infection with other virus
strains. In this study, we have examined the role of neutrophils during infection of mice with
influenza virus strain HKx31, a virus strain of the H3N2 subtype and of moderate virulence for
mice, to determine the role of neutrophils in the early phase of infection and in clearance of
influenza virus from the respiratory tract during the later phase of infection.
Methods: The anti-Gr-1 monoclonal antibody (mAb) RB6-8C5 was used to (i) identify neutrophils
in the upper (nasal tissues) and lower (lung) respiratory tract of uninfected and influenza virus-
infected mice, and (ii) deplete neutrophils prior to and during influenza virus infection of mice.
Results: Neutrophils were rapidly recruited to the upper and lower airways following influenza
virus infection. We demonstrated that use of mAb RB6-8C5 to deplete C57BL/6 (B6) mice of
neutrophils is complicated by the ability of this mAb to bind directly to virus-specific CD8+ T cells.
Thus, we investigated the role of neutrophils in both the early and later phases of infection using
CD8+ T cell-deficient B6.TAP-/- mice. Infection of B6.TAP-/- mice with a low dose of influenza virus
did not induce clinical disease in control animals, however RB6-8C5 treatment led to profound
weight loss, severe clinical disease and enhanced virus replication throughout the respiratory tract.
Conclusion: Neutrophils play a critical role in limiting influenza virus replication during the early
and later phases of infection. Furthermore, a virus strain of moderate virulence can induce severe
clinical disease in the absence of an effective neutrophil response.
Background
Host defence against influenza virus infection depends on
a complex interplay of innate (non-specific) and adaptive
(specific) components. The development of specific
immunity (antibodies and cell-mediated immunity) fol-
lowing infection is of undoubted importance in recovery
from infection and resistance to re-infection. Also crucial,
however, are pre-existing and rapidly induced innate
defence mechanisms which play a critical role in the ini-
tial phase of a primary infection, providing a barrier to
establishment of a virus and limiting its spread in host tis-
sues in the days before a specific immune response devel-
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ops. Following inhalation, influenza virus infection is
limited to epithelial cells lining the bronchotracheal sys-
tem, alveolar epithelial cells and airway macrophages [1].
Intranasal administration of mouse-adapted strains of
influenza virus leads to development of pneumonia, sim-
ilar to that observed in human influenza disease. Acute
infection is characterized by rapid production of cytokines
and chemokines and the subsequent recruitment of
inflammatory cells, including macrophages, neutrophils
and lymphocytes to the airways. The early inflammatory
response aims to limit virus growth in the early phase of
infection, prior to the recruitment and activation of virus-
specific T lymphocytes (reviewed in [2]).
Although neutrophils have long been considered primary
effector cells against bacterial and fungal infections they
are also prominent components of inflammatory
responses induced by viral infections. Neutrophil infiltra-
tion is considered to be a characteristic feature in the early
phase of influenza infection in humans, ferrets and mice
[3]. Studies using mice irradiated to deplete neutrophils
[4] and tumour bearing mice with neutrophilic leukocyto-
sis [5] have suggested that neutrophils can play protective
roles against influenza virus infection in vivo using virus
strain A/PR/8/34. More recently, studies have used anti-
granulocyte receptor 1 (Gr-1) mAb RB6-8C5 to examine
the contribution of neutrophils to (i) protection in the
early phase and (ii) recovery in the late phase following
primary infection of mice with highly pathogenic or
mouse-adapted strains of influenza A virus [6,7]. Caution
must be extended in the interpretation of data obtained
following depletion of neutrophils with this mAb, partic-
ularly in the latter phase of infection, due to its docu-
mented cross-reactivity with additional leukocyte
populations, including CD8+ T cells [8-11].
Previous studies have focussed on the role of neutrophils
during infection with a virulent recombinant H1N1 virus
with genes from the 1918 influenza A virus [7] or with the
mouse-adapted PR8 strain [4-6]. Type A influenza viruses
of the H3N2 subtype have circulated in the human popu-
lation since their appearance in 1968 and severe disease is
generally associated only with the elderly and/or the
immunocompromised. In the mouse model, H3N2 sub-
type viruses show moderate to low virulence when com-
pared to mouse-adapted virus strains such as PR8 [12].
The current study was undertaken to clarify the role of
neutrophils in the upper and lower respiratory tract of
mice infected with a H3N2 subtype of moderate virulence
for mice. Whilst clear differences are likely to exist
between the virulence of a particular virus strain for
humans and mice, the mouse serves as a convenient
model to gain insight into factors that regulate neutrophil
recruitment and the role they play in vivo. In initial stud-
ies, mAb RB6-8C5 was found to bind to CD8+ T cells and,
in particular, to virus-specific CD8+ T cells which could be
isolated from the airways at high numbers after day 5
post-infection. Consequently, to investigate the role of
neutrophils during the latter stages of infection, CD8+ T
cell-deficient B6.TAP-/- mice were treated with RB6-8C5
during infection with a low dose of H3N2 subtype virus.
This treatment profoundly enhanced disease and mortal-
ity, confirming a critical role for neutrophils in limiting
influenza virus replication during the early and later
phases of infection.
Methods
Mice and viruses
C57BL/6 (B6) mice and TAP-knockout (B6.TAP-/-) mice
on a B6 background [13] were bred and housed in specific
pathogen-free conditions at the Department of Microbiol-
ogy and Immunology, University of Melbourne, Australia.
Adult male mice (6–10 week old) were used in all experi-
ments. The influenza A virus strain used in this study was
HKx31 (H3N2), a high-yielding reassortant of A/Aichi/2/
68 (H3N2) and A/PR/8/34 (PR8; H1N1) that bears the
HA and NA surface glycoproteins of A/Aichi/2/68 and the
internal genes of PR8 [14]. Virus was obtained from Alan
Hampson, World Health Organization Collaborating
Centre for Reference and Research on Influenza, Mel-
bourne, Australia. Virus was grown in 10-day embryo-
nated hen's eggs by standard procedures and titrated on
Madin-Darby canine kidney (MDCK) cells as described
[15].
Infection and treatment of mice
Groups of 5 mice were anaesthetized and infected via the
intranasal route with 105 PFU of HKx31 in 50 μl of phos-
phate buffered saline unless otherwise stated. Each day
mice were weighed and scored for clinical illness using the
following scale – 0 = no visible signs of disease; 1 = slight
ruffling of fur; 2 = ruffled fur, reduced mobility; 3 = ruffled
fur, reduced mobility, rapid breathing; 4 = ruffled fur,
minimal mobility, huddled appearance, rapid and/or
laboured breathing indicative of pneumonia. Animals
displaying evidence of pneumonia and/or having lost >
25% of their original body weights were euthanized. All
research complied with the University of Melbourne's
Animal Experimentation Ethics guidelines and policies.
To determine virus titres in organs, mice were euthanized
and lungs and nasal tissues were removed, homogenised
and clarified by centrifugation. Samples were assayed for
infectious virus by standard plaque assay on MDCK cells
in the presence of trypsin [15].
To deplete neutrophils in vivo, purified anti-Gr-1 rat mAb
(RB6-8C5) [16,17] was administered to mice via a combi-
nation of intraperitoneal (i.p.; 0.5 mg in 0.2 ml) and
intranasal (i.n.; 0.2 mg in 0.05 ml) routes. Mice were
treated 1 day prior to infection and every second dayRespiratory Research 2008, 9:57 http://respiratory-research.com/content/9/1/57
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thereafter. Control animals received either a similar dose
of purified whole rat IgG (Jackson Laboratories, USA) or
an equivalent volume of PBS alone. Neutrophil depletion
in the blood and the airspaces of the lung was confirmed
by differential leukocyte counts as described below.
To deplete CD8+ cells, mice received a single i.p. injection
of 1 mg/ml purified mAb YTS169.4 [18] (a kind gift from
Assoc. Prof. Andrew Lew and Dr. Yifan Zhan, The Walter
and Eliza Hall Institute of Medical Research, Melbourne,
Australia) while control mice received an equivalent dose
of rat IgG. The effectiveness of CD8 depletion was moni-
tored by flow cytometry analysis of spleen and bronchoal-
veolar lavage (BAL) cell preparations using PE-labelled
mAb 53-6.7, an anti-CD8 mAb that recognizes an epitope
distinct from that bound by mAb YTS169.
Recovery of immune cells
BAL, blood, lung and nasal tissue cells were obtained from
uninfected and virus-infected mice. Heparinized blood
was obtained by cardiac puncture using a 29-guage nee-
dle. For collection of BAL cells, mice were euthanized and
the lungs flushed three times with 1 ml of PBS through a
blunted 23-guage needle inserted into the trachea. Cells
from the nasal tissues (nasal cavity and nasal turbinates)
were obtained by cutting down the vertical plane of the
skull and scraping out the tissues and small bones from
both sides of the nasal passages. Single cell suspensions of
lung and nasal tissues were prepared by incubating sam-
ples with 2 mg/mL Collagenase A (Roche Diagnostics,
Mannheim, Germany) in serum-free RMPI 1640 medium
at 37°C for 30 minutes. Each sample was passed through
a wire mesh to obtain a single cell suspension. Blood,
BAL, lung and nasal tissue samples were treated with Tris-
NH4Cl (0.14 M NH4Cl in 17 mM Tris, adjusted to pH 7.2)
to lyse erythrocytes and washed in RPMI 1640 medium
supplemented with 10% FCS (RF10). Cell viability was
assessed via trypan blue exclusion and cell numbers were
determined by counting in a hemocytometer.
Differential leukocyte counts, cell staining and flow 
cytometry
Leukocytes present in blood, BAL, lung and nasal tissue
samples were analyzed by differential leukocyte counts or
by flow cytometry. For differential counts, aliquots of
approximately 5 × 104 cells were cytocentrifuged onto
glass microscope slides, dried and stained with Diff Quick
(Lab Aids, Australia). Slides were examined using a light
microscope and a minimum of 100 cells in 4–8 random
fields was counted (×1000 magnification). Macrophages,
lymphocytes and neutrophils were identified by their dis-
tinct nuclear morphologies.
For flow cytometry analysis, single cell suspensions of
blood, BAL and nasal tissue cells were incubated on ice for
20 minutes with supernatants from hybridoma 2.4G2 to
block Fc receptors and then stained with appropriate com-
binations of fluorescein isothiocyanate (FITC), phyco-
erythrin (PE), allophycocyanin (APC) or biotinylated
monoclonal antibodies to Gr-1 (RB6-8C5), CD45.2
(104), CD8a (53-6.7), CD4 (GK1.5), B220 (RA3-6B2),
NK1.1 (PK136), CD3e (145-2C11), CD11a (M17/4),
CD11b (M1/70), CD18 (C71/16), CD49d (MFR4.B),
CD62L (MEL-14), CD69 (H1.2F3), CD11c (HL3, all from
BD PharMingen), F4/80 (BM8, Caltag Lab.) or CD107a/
LAMP-1 (1D4B, a kind gift from Prof. Ken Shortman, Wal-
ter and Eliza Hall Institute of Medical Research, Mel-
bourne, Australia). In some experiments, cells were
stained with PE or APC-labelled DbPA224 (SSLENFRAYV)-
specific tetramers (a gift from Laureate Prof. Peter
Doherty, Department of Microbiology and Immunology,
The University of Melbourne) for 60 minutes at room
temperature prior to staining with anti-CD8. Propidium
iodide (PI; 10 μg/ml) was added to each sample and cells
were analysed on a FACS Calibur flow cytometer collect-
ing data from at least 50,000 living (PI-) cells. Leukocyte
populations were sorted using a MoFlo cell sorter (Dako-
Cytomation, Denmark).
Measurement of intracellular hydrogen peroxide
Blood and BAL cells were assessed for intracellular hydro-
gen peroxide (H2O2) using an established protocol [19].
Fluorescent 6-carboxy-2'7'-dichlorofluorescien diacetate,
di(acetoxymethlyl ester) (H2DCF; Molecular Probes,
USA) is taken up by cells and in the presence of H2O2 is
oxidized to the green florescent product 2'7'-dichloroflu-
orescein (DCF) which is trapped within the cell and
detectable by flow cytometry (FL-1 channel). H2DCF (50
μM) was added to cells and incubated for 1 hour at either
4°C or 37°C and DCF levels were determined in Gr-1high
cells by flow cytometry.
Statistical analysis
When comparing two sets of values to each other, Stu-
dent's t test (two-tailed, two-sample equal variance) was
used. A p value of ≤ 0.05 was considered statistically sig-
nificant.
Results
Rapid and transient neutrophil response in the respiratory 
tract following influenza virus infection
A number of studies have identified neutrophils by flow
cytometry as Gr-1high inflammatory cells recruited to sites
of infection [11,20]. Flow cytometric analysis of cells
present in BAL and nasal tissues (Fig. 1A) of mice infected
with influenza virus strain HKx31 revealed a population
of CD45+/Gr-1high cells, a phenotype consistent with that
of neutrophils. To confirm the identity of this population,
inflammatory cells were recovered from BAL or nasal tis-
sues of virus-infected mice, stained with fluorescentRespiratory Research 2008, 9:57 http://respiratory-research.com/content/9/1/57
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labelled mAbs and the Gr-1high population purified by
FACS. Microscopic analysis demonstrated that the Gr-
1high population comprised > 90% cells exhibiting a cellu-
lar morphology characteristic of neutrophils (data not
shown). Gr-1 expression was restricted to inflammatory
cells as only cells expressing the common leukocyte anti-
gen CD45 co-stained for Gr-1.
We next examined the kinetics of neutrophil recruitment
and accumulation in the respiratory tract following infec-
tion with a non-lethal dose of influenza virus strain
HKx31. Neutrophils (CD45+/Gr-1high) were detected at
low numbers in the airspaces of uninfected mice where
they comprised < 2% of CD45+ BAL cells. Following infec-
tion, neutrophil numbers in the BAL increased rapidly,
peaking 3–5 days p.i. and declining thereafter (Fig. 1B,
upper panel); the neutrophil influx was shown to corre-
late with a reduction in virus titres in the lung (Fig. 1C,
upper panel), consistent with a role in early host defence.
Neutrophil accumulation was also observed in the upper
airways following influenza virus infection (Fig. 1B, lower
panel). Recruitment to the nasal tissues was somewhat
delayed compared to the lung, with peak numbers
recorded 7–9 days post-infection; again, the timing of the
neutrophil influx correlated with the reduction of virus
titres in the upper respiratory tract (Fig. 1C, lower panel).
Neutrophil recruitment to the airways was a consequence
of active viral replication as neither PBS nor UV-inacti-
vated virus induced neutrophil recruitment to the airways
of the lung (data not shown). Thus, during a non-lethal
influenza virus infection neutrophils were a major com-
ponent of the inflammatory cell population recruited to
the upper and lower respiratory tract.
Phenotypic analysis of Gr-1high cells from the airways of 
uninfected and influenza virus-infected mice
We next examined a range of phenotypic markers on Gr-
1high cells from the blood and BAL of uninfected animals
and from the BAL of mice 3 days after infection with
HKx31 in an attempt to identify markers associated with
neutrophil activation during influenza infection. As neu-
trophil numbers are particularly low in the BAL from
uninfected mice (Fig. 1B), erythrocyte counts confirmed
blood contamination to be < 0.01% in all samples ana-
lyzed. Adhesion molecules play a critical role in neu-
trophil recruitment and extravasation from the blood to
Neutrophil response in the upper and lower airways following influenza virus infection of mice Figure 1
Neutrophil response in the upper and lower airways following influenza virus infection of mice. Groups of 5 mice were infected with 105 PFU 
of HKx31via the intranasal route. At the times indicated, mice were euthanized and neutrophils in the BAL (upper panels) and nasal tissues (lower panels) 
were identified as Gr-1high cells by flow cytometry and quantitated. (A) Representative dot plots of Gr-1high cells recovered from BAL and nasal tissues 3 
days after infection with HKx31. Graphs show Gr-1 staining of CD45+ leukocytes and the gate used to define Gr-1high neutrophils. (B) The number of neu-
trophils in BAL and nasal tissues of naïve mice or mice at various times post-infection. A minimum of 50,000 living cells (PI-) were collected and analyzed 
from each mouse. (C) Viral loads in the lung (upper panel) and nasal tissues (lower panel) were determined by plaquing homogenates on MDCK monolay-
ers. Data in panels (B) and (C) show the mean ± 1 SD (n = 5 mice/group). In panel (C), the dotted line represents the detection limit for the plaque assay. 
The data are representative of 2 or more independent experiments.
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sites of infection and previous studies have reported mod-
ulation of adhesion molecules expressed by pulmonary
neutrophils during influenza infection [20]. Our data
indicate that CD11b and CD18 are constitutively
expressed on blood neutrophils and expression is upregu-
lated on airway neutrophils in the presence or absence of
influenza infection (Fig. 2A). CD49d expression is negli-
gible on circulating neutrophils and upregulated on air-
way neutrophils in a manner that is also independent of
viral infection. Conversely, CD62L is expressed at high
levels on blood neutrophils but downregulated following
migration to the airways of either infected or uninfected
mice. Clearly, these data indicate that modulation of
many adhesion molecules appears to be associated with
recruitment to the airways rather than a consequence of
viral infection. A notable exception was CD11a, which in
multiple experiments was found to be upregulated on
neutrophils from HKx31-infected mice, indicating a
degree of virus-specific modulation.
Following a screen of numerous adhesion molecules and
cell surface markers (for example, CD31 and CD38, both
of which were expressed at low levels on blood and BAL
neutrophils) we found CD69 to be the only other marker
suitable to discriminate between airway neutrophils from
uninfected and virus-infected mice. As seen in Fig. 2A,
CD69 is poorly expressed on blood and BAL neutrophils
from uninfected mice, but strongly upregulated during
viral infection, perhaps reflecting the responsiveness of
CD69 to upregulation in the presence of pro-inflamma-
tory cytokines such as IFN-α and IFN-γ [21] which would
be produced at high levels in the lungs of infected, but not
naïve, mice.
Neutrophils contain antimicrobial products stored in
intracellular granules that may be released during infec-
tion. Airway neutrophils from infected and uninfected
mice were more granular than those recovered from the
blood (Fig. 2B), suggesting upregulation of intracellular
effector molecules following transmigration to the air-
ways. BAL neutrophils from both infected and uninfected
mice also showed enhanced surface expression of lyso-
somal-associated membrane protein-1 (LAMP-1; Fig. 2B),
a protein generally associated with intracellular lysosomal
membranes that has been shown to be expressed on the
surface of human neutrophils following degranulation
[22]. Finally, as reactive oxygen species (ROS) are pro-
duced during influenza infections [23], we examined ROS
production in murine neutrophils by incubating blood or
BAL cells with H2DCF which, in the presence of H2O2, is
oxidized to the green fluorescent product DCF [24]. Blood
neutrophils and BAL neutrophils from uninfected mice
showed a significant increase in the MFI of intracellular
DCF generated following incubation at 37°C when com-
pared to control cells incubated at 4°C (Fig. 2B). It is note-
Figure 2
Expression of adhesion molecules and cell markers by Gr1high neutrophils 
from naive and influenza virus-infected mice. Uninfected mice were euthanized 
and neutrophils in the blood or BAL from pools of 5 mice were examined for expres-
sion of cell markers (grey histograms) and appropriate isotype controls (white histo-
grams) via fluorescence intensity. Mice infected with 105 PFU of HKx31 were 
euthanized at day 3 post-infection and neutrophils in pooled BAL samples were also 
examined for expression of (A) cell surface adhesion molecules (B) other markers 
associated with neutrophil activation including (i) granularity, (ii) cell surface expres-
sion of LAMP-1 and (iii) intracellular H2O2 production. A minimum of 50,000 living 
cells (PI-) were collected and analyzed from each sample and numbers shown beside 
each histogram represent the MFI of each surface marker on the neutrophil popula-
tions indicated, except for H2O2 production, where numbers shown represent the 
fold increase in MFI between samples incubated at 4°C and those incubated at 37°C. 
The data is representative of at least 2 independent experiments.
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worthy that the fold increase in MFI of DCF between 4°C
and 37°C was consistently higher in BAL neutrophils
from virus-infected mice compared to BAL neutrophils
from naïve animals (increases of 1.7, 5.3 and 4.5-fold in
BAL neutrophils from uninfected mice compared to 7.6,
11 and 11-fold increases in BAL neutrophils from day 3
HKx31-infected mice in 3 independent experiments), sug-
gesting a higher production of ROS during influenza virus
infection.
Reduced survival and elevated virus titres in neutropenic 
mice
To confirm a role for neutrophils in host defence during
influenza virus infection we compared survival and virus
titres in influenza virus-infected neutropenic (RB6-8C5-
treated) and control (PBS- or IgG-treated) mice. We found
that a combination of systemic (intraperitoneal) and local
(intranasal) treatments was necessary to obtain optimal
neutrophil depletion using mAb RB6-8C5 as while sys-
temic depletion alone was sufficient to reduce numbers of
blood neutrophils to < 5%, in the absence of an intranasal
administration of RB6-8C5, significant numbers of neu-
trophils accumulated in the airspaces of the lung (data not
shown). As seen in Fig. 3A, none of the PBS- or IgG-treated
mice infected with HKx31 succumbed to infection over
the 11 day monitoring period whereas all virus-infected
mice treated with RB6-8C5 were euthanized 5–6 days
post-infection. PBS- or IgG-treated mice showed transient
weight loss during the first 7 days of infection, after which
time mice fully recovered whereas neutropenic mice lost
weight rapidly and did not recover (Fig. 3B). Thus, a non-
lethal infection becomes lethal following neutrophil
depletion of B6 mice.
We next compared virus titres in the upper and lower res-
piratory tract of infected neutropenic and control mice
following infection with HKx31. Virus titres were signifi-
cantly higher throughout the respiratory tract of RB6-8C5-
treated mice at days 1, 3 and 5 when compared to either
control group (Fig. 3C). These data suggest that neu-
trophils contribute to early control of viral replication in
the upper and lower respiratory tract and promote sur-
vival following infection with a sub-lethal dose of influ-
enza virus.
RB6-8C5 binds to and depletes CD8+ T cells during 
influenza virus infection
The RB6-8C5 hybridoma was originally described as
secreting an antibody specific for granulocyte receptor 1
(Gr-1) [17,25]. Subsequent studies have shown RB6-8C5
to recognize Ly6G, a marker expressed at high levels on
granulocytes, and Ly6C expressed by other cell types
including subsets of lymphocytes [8,26-28]. To address
the possibility that the effects of RB6-8C5 on HKx31-
treated mice resulted from cross-reactive depletion of Ly-
Figure 3
RB6-8C5 treatment during influenza infection exacerbates dis-
ease and leads to increased virus growth in the airways. Groups of 
5 B6 mice were treated with mAb RB6-8C5 (RB6) to deplete neutrophils, 
or with either rat IgG (IgG) or diluent alone (PBS) 1 day prior to infection 
with 105 PFU of HKx31, and every second day thereafter as described in 
Materials and Methods. (A) Animals displaying evidence of pneumonia and/
or having lost > 25% of their original body weights were euthanized. Sur-
vival curves were constructed using pooled data from 2 independent 
experiments (n = 10 mice/group) (B) Mice were weighed daily and results 
expressed as the mean percent weight change of each group + SEM, com-
pared to the weight immediately prior to infection. (C) Growth and repli-
cation of influenza virus in the upper and lower respiratory tract. At 
various times post-infection, lungs and nasal tissues were removed and lev-
els of infectious virus were assayed in clarified homogenates by plaque 
assay on MDCK cells. Data represents the mean virus titre ± 1 SD (n = 5 
mice/group). ** indicates viral titres of RB6-8C5-treated mice significantly 
different to those of IgG-treated controls (p < 0.01, Student's t-test). PBS- 
and IgG-treated controls were not significantly different to each other at 
any time-point tested.
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6C+ cells a number of approaches were taken. First, flow
cytometry studies confirmed that Gr-1high cells from the
lungs of HKx31-infected mice at day 3 post-infection did
not express markers characteristic of B cells (B220+), T
cells (CD3ε+) or NK cells (NK1.1+) (data not shown),
although intermediate levels of Gr-1 expression were
observed on CD8+ T cells and, to a lesser extent, on NK
cells and B cells recovered from the lungs of virus-infected
mice (Fig. 4A). Second, we examined the effect of RB6-
8C5 treatment of mice at day -1, +1 and +3 (relative to
infection) on the cellularity of cell suspensions prepared
from the lungs of mice 5 days after infection with 105 PFU
of HKx31. Treatment of mice with RB6-8C5 did not
reduce numbers of CD4+ T cells or B cells in lung cell sus-
pensions prepared from HKx31-infected mice (Fig. 4B).
Of interest, (i) numbers of CD8+ T cells were significantly
reduced in the lungs of RB6-8C5-treated mice in multiple
experiments (p < 0.001 in 2 experiments and p < 0.02 in a
third), and (ii) numbers of NK cells were significantly
reduced in 2 experiments (p = 0.015, p = 0.022) but not in
3 others (p = 0.54, 0.27 and 0.35). The variable effects of
RB6-8C5 treatment on NK cells may relate to the interme-
diate levels of expression observed in this cell population,
as seen in Fig 4A.
We have found F4/80 to be a useful marker for identifica-
tion of resident airway macrophages, however we find this
marker to be down-regulated on airway macrophages dur-
ing influenza infection (data not shown). Therefore, we
used cytospin analysis to identify and enumerate mono-
cyte/macrophage populations recovered in the BAL of
IgG-treated and RB6-treated mice 5 days after infection
with 105 PFU of HKx31. Whilst a number of studies have
reported Gr-1 expression on monocytes and macrophages
[29-31], we found that macrophage numbers were not sig-
nificantly reduced by treatment of mice with anti-Gr-1
antibodies (6.31 × 105 ± 4.61 × 104 and 8.04 × 105 ± 7.7 ×
104 for IgG-treated and RB6-treated mice, respectively).
It is well documented that virus-specific CD8+ T cells play
a critical role in recovery from influenza infection and in
resistance to re-infection [2]. Furthermore, depletion of
CD8+ T cells in vivo following treatment with RB6-8C5 has
been reported previously [10,11], although the effects of
this mAb on influenza virus-specific CD8+ T cells are
unknown. It was therefore of interest to determine the
timing of CD8+ T cell recruitment to the airways and the
effects of RB6-8C5-treatment on this cell population.
First, we determined the kinetics of total (Fig. 5A) and
virus-specific (Db-PA224-tetramer+, Fig. 5B) CD8+ T cell
recruitment to the upper and lower airways. Numbers of
total and DbPA224 epitope-specific CD8+ T cells were low 1
to 5 days post-infection and increased considerably there-
after, peaking at day 7–9 post-infection. Furthermore, we
could demonstrate high levels of direct binding of fluoro-
chrome-labelled RB6-8C5 to both total (Fig. 5C) and
DbPA224 epitope-specific (Fig. 5D) CD8+ T cells isolated
from the lungs of HKx31-infected mice when compared to
the weaker binding of RB6-8C5 to CD8+ cells recovered
from the spleen of uninfected mice (Fig. 5E), indicating
that Gr-1 expression is upregulated on airway CD8+ T cells
during influenza virus infection.
The effects of RB6-8C5 treatment on CD8+ T cells was
unlikely to be a major factor in our studies as all neutro-
penic mice had succumbed to HKx31 infection by day 5
post-infection (Fig. 3A). To confirm this hypothesis, mice
were depleted of CD8+ cells prior to and during infection
with HKx31 and the inflammatory response and virus
titres determined in the lung. Treatment of mice with anti-
CD8+ antibody reduced (i) total CD8+ T cell numbers by >
90% in spleen and BAL, and (ii) DbPA224 epitope-specific
CD8+ T cells by > 95% in BAL at day 5 post-infection but
did not reduce neutrophil numbers at either site (data not
Expression of Gr-1 on lymphocytes recovered from the  lungs of influenza virus-infected mice Figure 4
Expression of Gr-1 on lymphocytes recovered from the lungs of influenza 
virus-infected mice. (A) Binding of fluorescent-labelled RB6-8C5 to 
NK1.1+ lymphocytes, CD4+ or CD8+ T lymphocytes and B cells (B220+ 
lymphocytes) from lungs of uninfected mice (white histograms) or mice 3 
days after infection with 105 PFU of HKx31 (grey histograms). Samples 
represent pooled lung cell suspensions from groups of 3–5 uninfected or 
virus-infected mice. (B) Cellularity of lung cell suspensions from IgG-
treated and RB6-8C5-treated mice 5 days after infection with 105 PFU of 
HKx31. Mice treated with either IgG or RB6-8C5 (at days -1, +1 and +3, 
as described in Materials and Methods) were infected at day 0 with 105 
PFU of HKx31 and lung cell suspensions were prepared from lung tissue at 
day 5 post-infection. Shown are the mean numbers (± SD) of total leuko-
cytes (CD45+), NK cells (NK1.1+ lymphocytes), B cells (B220+ lym-
phocytes), CD4+ T cells and CD8+ T cells recovered from the lungs of 
IgG-treated or RB6-8C5-treated mice (n = 5 mice/group). Data are repre-
sentative of at least 2 independent experiments. ** p = 0.015 for NK cells, 
p = 0.017 for CD8+ T cells.
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shown). Moreover, no differences in viral titres were
recorded in lung and nasal tissue homogenates of CD8-
depleted versus control mice (PBS- or IgG-treated) at days
3 and 5 after infection with HKx31 (data not shown),
indicating that the absence of CD8+ cells, including CD8+
T cells, does not have a major impact on early viral repli-
cation.
The effects of RB6-8C5-induced neutropenia during 
influenza virus infection of mice lacking effective CD8+ T 
cell immunity
We have confirmed a protective role for neutrophils in the
early response to influenza virus infection [6,7], however
studies examining their role in viral recovery and clear-
ance are complicated by the cross-reactivity of the RB6-
8C5 antibody with virus-specific CD8+ T cells. Therefore,
we treated B6.TAP-/- mice, which have defective CD8+ T
cell-mediated immunity [13], with RB6-8C5 to induce
neutropenia prior to and during infection with HKx31.
Preliminary studies established no differences in numbers
of BAL neutrophils recovered from HKx31-infected B6 or
B6.TAP-/- mice at days 3 and 7 post-infection (data not
shown).
Initial studies demonstrated that B6.TAP-/-  mice were
more sensitive to HKx31 infection than immunocompe-
tent B6 animals. Following infection with 104 PFU of
HKx31, survival (Fig. 6A) and weight loss (Fig. 6B) was
similar in groups of IgG-treated B6 or B6.TAP-/- mice up to
day 6 post-infection, however after this time recovery was
significantly delayed in B6.TAP-/- mice. The rapid recovery
of B6 mice after day 6 post-infection corresponded with a
massive influx of virus-specific CD8+ T cells into the air-
ways at day 7 post-infection (Fig. 5A/B). In contrast, total
CD8+ and DbPA224 epitope-specific CD8+ T cells recovered
by BAL from infected B6.TAP-/- mice were < 1% of those
from B6 mice at this time (data not shown). Of interest
B6.TAP-/- mice did recover from influenza infection, albeit
with delayed kinetics, suggesting that other components
of adaptive immunity can mediate viral clearance in the
absence of effective CTL responses.
The effects of RB6-8C5 treatment on the course of influ-
enza virus infection were compared in B6 and B6.TAP-/-
mice using HKx31 at an infectious dose of either 104 or
102 PFU. Following infection with 104 PFU of HKx31,
both B6 and B6.TAP-/- mice treated with RB6-8C5 lost
weight rapidly compared to their respective IgG-treated
controls, with all mice euthanized by day 7 post-infection
(Fig. 6A/B). Inoculation of B6 or B6.TAP-/- mice with 102
PFU of HKx31 led to no significant loss in body weight or
signs of disease in IgG-treated controls, yet RB6-8C5 treat-
ment led to rapid and profound weight loss in both B6
and B6.TAP-/- mice and all animals were euthanized 7–8
days post-infection (Fig. 6A/B). Neutrophil-depleted B6
or B6.TAP-/- mice infected with 102 PFU of HKx31 dis-
played hunched posture, lethargy and laboured breathing
by days 7–8 post-infection (clinical score 3 – 4, as
described in Materials and Methods) while IgG-treated
controls showed no visible signs of infection (clinical
score < 1).
We next examined viral load in the upper and lower respi-
ratory tract of B6 and B6.TAP-/- mice 7 days after infection
with 102 PFU of HKx31. Consistent with the profound
impairment of antiviral CD8+ T cell responses observed in
B6.TAP-/- mice (see above), virus titres recovered from the
lungs and nasal tissues of IgG-treated B6.TAP-/- mice were
markedly higher compared to IgG-treated B6 mice (Fig.
6C). Despite these differences, RB6-8C5 treatment of
either B6 or B6.TAP-/- mice was associated with signifi-
cantly higher levels of virus growth throughout the respi-
ratory tract when compared to their respective IgG-treated
controls (Fig. 6C). Together, these data indicate that neu-
trophils play an essential role in the recovery of CD8+ T
cell-deficient B6.TAP-/- mice as neutrophil depletion was
Recruitment of CD8+ T cells and upregulation of Gr-1  expression during influenza infection Figure 5
Recruitment of CD8+ T cells and upregulation of Gr-1 expression 
during influenza infection. Groups of 5 mice were infected with 105 
PFU of HKx31 and at various time points post-infection mice were eutha-
nized and BAL cells were analyzed and quantitated by flow cytometry. (A) 
Total CD8+ T cells and (B) DbPA224-specific CD8+ T cells are shown. Data 
are presented as the mean ± SD cell numbers from the BAL or nasal tis-
sues (NT) of uninfected and virus-infected mice. The expression of Gr-1 
was determined on (C) CD8+ T cells and (D) DbPA224-specific CD8+ T 
cells recovered by BAL at day 7 post-infection, or on (E) CD8+ T cells 
from the spleen of uninfected mice. Grey histograms represent binding of 
PE-labelled RB6-8C5 and clear histograms represent binding of an appro-
priate PE-labelled isotype control. Data shown in (C), (D) and (E) repre-
sent a single mouse from a group of 5. All data are representative of 2 or 
more independent experiments. A minimum of 50,000 living cells (PI-) 
were analyzed for each sample.
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associated with enhanced virus replication and a pro-
found acceleration of disease in mice infected with a low
dose of HKx31.
Discussion
The results of this study confirm a protective role for neu-
trophils during influenza infection and establish their crit-
ical role in mediating clearance of influenza virus from the
respiratory tract of mice infected with a strain of moderate
virulence. Treatment with mAb RB6-8C5 was found to
induce profound depletion of neutrophils in the blood
and throughout the respiratory tract, accompanied by
enhanced virus titres and exacerbated morbidity and mor-
tality compared to control mice. A number of observa-
tions indicate that our findings are attributable to
neutrophil depletion. First, neutrophils were recruited to
the airways as early as 8 hrs post-infection (data not
shown) and their presence correlated with suppressed
virus replication in the airways early after infection. Sec-
ond, while we could detect direct binding of mAb RB6-
8C5 to virus-specific CD8+ T cells, a direct effect on CD8+
T cells is unlikely to account for our results because (i)
CD8+ T cell numbers in the airways were particularly low
up to day 5 post-infection, (ii) depletion of CD8+ T cells
with anti-CD8 mAb YTS169.4 had no effect on viral titres
up to and including day 5 post-infection. Furthermore,
neutrophil depletion of B6.TAP-/-  mice, which have
impaired CD8+ T cell immunity, was accompanied by
severe disease and enhanced virus replication throughout
the airways demonstrating a critical role for neutrophils in
mediating viral clearance in this model.
We have demonstrated that neutrophils accumulate in
both the upper and lower airways following infection
with influenza virus strain HKx31. Initial studies aimed to
address the activation status of neutrophils in the airways.
Adhesion molecules such as CD11a, CD11b, CD18,
CD31, CD38 and CD49d play an important role in neu-
trophil transmigration [32] and modulation of adhesion
molecule expression has been associated with activation
during influenza virus infection [20]. We report that much
of the modulation observed during influenza virus infec-
Effects of RB6-8C5 treatment on influenza infection of CD8+ T cell impaired B6.TAP-/- mice Figure 6
Effects of RB6-8C5 treatment on influenza infection of CD8+ T cell impaired B6.TAP-/- mice. Groups of 5 B6 or B6.TAP-/- mice were treated 
with mAb RB6-8C5 (RB6) to deplete neutrophils, or with either rat IgG (IgG) or diluent alone (PBS) 1 day prior to influenza virus infection and every sec-
ond day thereafter as described in Materials and Methods. (A) Survival data and (B) weight loss following infection with 104 PFU (high dose) or 102 PFU 
(low dose) of HKx31. Mice were weighed daily and results expressed as the mean percent weight change of each group ± SEM, compared to the weight 
immediately prior to infection. For survival curves, data has been pooled from 2 independent experiments (n = 10 mice/group) and for weight change data 
is taken from one of two independent experiments (n = 5 mice/group) (C) Viral growth in the upper and lower respiratory tract 7 days after infection with 
102 PFU of HKx31. Viral loads were determined in homogenates prepared from lungs and nasal tissue at day 7 post-infection by plaque assay on MDCK 
cell monolayers. Data represent the mean ± 1 SD from 4–5 mice and the dotted line represents the detection limit of the plaque assay. ** indicates viral 
titres of RB6-8C5-treated mice significantly different to those of the relevant IgG-treated controls (p < 0.01, Student's t-test).
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tion, for example the increased expression of CD11b or
CD18 (Fig. 2A), was also observed on the very low num-
bers of neutrophils recovered from BAL of uninfected
mice, suggesting that upregulation is also required for
transmigration into the airspaces in the absence of viral
infection. Upregulation of CD11a was, however, consist-
ently observed on BAL neutrophils from virus-infected
mice compared to naïve controls, suggesting an element
of virus-specific modulation. Relative to neutrophils
present in the blood, we also found that airway neu-
trophils from uninfected and infected mice displayed
increased granularity, surface expression of LAMP-1 and
production of ROS (Fig. 2B), markers typically associated
with activation. These findings are consistent with non-
specific activation of neutrophils following transmigra-
tion into the airways, such that in the absence of infection
the low numbers present in the airways are likely activated
in response to inhaled stimuli such as dust and other irri-
tants.
Early studies using gamma-irradiated and carrageenan-
treated mice suggested a protective role for neutrophils in
the early phase of influenza infection [4] and subsequent
studies have utilized mAb RB6-8C5 in immunocompetent
mice to demonstrate a role for neutrophils in early [6,7]
and later-phase protection [6] against highly virulent virus
strains. Caution must, however, be exercised interpreting
data examining the contribution of neutrophils to protec-
tion in the later-phase infection when using immunocom-
petent mice as we have demonstrated direct binding of
mAb RB6-8C5 to virus-specific CD8+ T cells and these cells
may also be depleted as a result of RB6-8C5 treatment. A
number of factors may contribute to the protective role of
neutrophils in the early phase of infection although exact
mechanisms underlying their protective effects are yet to
be determined. Neutrophils are non-permissive to influ-
enza virus infection [4], adhere to influenza virus-infected
cells [33] and mediate phagocytosis of virus-infected,
apoptotic cells [34]. In addition, neutrophils have been
shown to produce a variety of immune mediators known
to display potent antiviral activity against influenza virus,
including ROS [23], innate pattern recognition receptors
of the defensin [35,36] and pentraxin [37,38] super-
families and cytokines such as TNF-α [39]. In the late
phase of infection, studies have indicated that cooperative
interactions between neutrophils and antibody may con-
tribute to protection against influenza infection [6].
Virus-specific CD8+ T cells play an important role in con-
tainment and clearance of influenza virus from infected
tissue [2]. Thus, any direct effect of mAb RB6-8C5 on
CD8+ T cell numbers may contribute to the severe weight
loss and disease observed in the late phase of influenza
infection in neutropenic mice. In some studies, mAb RB6-
8C5 has been reported not to bind CD8+ T cells from
naïve animals [40] but others have reported anti-Gr-1 to
bind and deplete Ly-6C+ memory-type CD8+ T cells [9].
While anti-Gr-1 antibodies showed minimal cross-reactiv-
ity with CD8+ T cells from mice infected with a neuro-
tropic strain of mouse hepatitis virus [11], we clearly
demonstrate direct binding of mAb RB6-8C5 to virus-spe-
cific CD8+ T cells isolated from the site of influenza virus
infection (Fig. 5D). These findings are consistent with
direct depletion of CD8+ T cells following RB6-8C5 treat-
ment of influenza virus infected mice and indicate that
caution must be exercised when interpreting data
obtained using neutrophil depleted mice after day 5 post-
infection, following expansion and release of CD8+ T cells
in B6 animals.
Despite being somewhat more sensitive to influenza
virus, B6.TAP-/- mice were able to clear infection in the
absence of effective antiviral CD8+ T cell immunity fol-
lowing inoculation with 104 PFU of HKx31. Of interest
B6.RAG-/- mice, which are entirely deficient of T cells and
B cells, were highly sensitive to infection with an equiva-
lent dose of HKx31 such that all mice succumbed to infec-
tion 5 days after inoculation (data not shown) arguing
that other aspects of adaptive immunity such as CD4+ T
cells and/or antibody responses play a critical role in con-
trol and clearance of virus from B6.TAP-/- mice. Treatment
of influenza virus-infected B6.RAG-/- mice with mAb RB6-
8C5 accelerated weight loss and clinical disease such that
all mice were euthanized by day 3 post-infection (data not
shown) demonstrating that in the absence of adaptive
immunity neutrophils play a critical role in restricting
early virus replication. The effects of neutrophil depletion
could not be studied in later phases of infection due to the
exquisite sensitivity of B6.RAG-/- mice to influenza infec-
tion.
Treatment of B6 mice or CD8+ T cell-deficient B6.TAP-/-
mice with mAb RB6-8C5 induced profound weight loss
and clinical disease following infection with 104 or 102
PFU of HKx31. It is interesting to note that following
infection with a low dose (102 PFU) of HKx31, weight loss
profiles were remarkably similar for RB6-8C5 treated B6
and B6.TAP-/- mice; in either case, virus-infected animals
treated with IgG showed no significant weight loss whilst
RB6-8C5 treated mice lost weight rapidly and were eutha-
nized by day 7 post-infection. The mechanisms underly-
ing the profound disease phenotype observed in the
neutrophil-depleted mice are yet to be fully elucidated.
Virus titres recovered from the airways of RB6-8C5-treated
mice were 10–100 fold higher than those from control
animals at day 7 post-infection (Fig. 6C) and this
increased viral burden would certainly be expected to con-
tribute to disease. Although RB6-8C5 treatment has been
associated with depletion of a Gr-1+ subset of monocytes
[29-31], we used differential leukocyte counts to demon-Respiratory Research 2008, 9:57 http://respiratory-research.com/content/9/1/57
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strate that numbers of inflammatory macrophages/mono-
cytes and lymphocytes recovered from the airways of
control and neutrophil-depleted B6.TAP-/- mice were not
different at this time were similar (data not shown), argu-
ing that unwanted depletion of additional leukocyte pop-
ulations was not a major factor contributing to severe
clinical disease. In addition, these data also confirm that
the morbidity and mortality associated with RB6-8C5
treatment of mice is not due to an overwhelming accumu-
lation of leukocyte populations in the airways.
Inoculation of mice with either a high (105 PFU) or low
(102 PFU) dose of HKx31 resulted in distinct kinetics of
viral replication and this in turn is likely to impact on dis-
ease pathogenesis. After inoculation with 105  PFU of
HKx31, virus titres were high early after inoculation and
then declined over the course of infection (Fig. 1C). In
contrast inoculation with 102 PFU resulted in increased
titres of 103-104 PFU in the lung at day 7 post-infection
(Fig. 6C). Neutrophil depletion of mice infected with
either high (Fig. 3) or low (Fig. 6) dose of HKx31 was
associated with enhanced viral replication and 100%
mortality however viral titres in neutrophil-depleted mice
infected with low dose HKx31 at day 7 post-infection (a
time associated with a lethal outcome) were similar to
those recovered from the lungs of IgG-treated controls
infected with a high dose of HKx31 at day 5 post-infection
(not associated with a lethal outcome) indicating that
viral titres alone do not determine survival during influ-
enza infection. Therefore, while neutrophils play a role in
control of viral replication following inoculation with
either high or low virus dose, they may also play a critical
role in shaping or modulating 'protective' inflammatory
responses, perhaps via the secretion of immunomodula-
tory cytokines and chemokines. Cytokine dysregulation
and aberrant innate responses have been proposed to con-
tribute to the pathogenesis of lethal influenza infections
[41-43] and could perhaps contribute to the severe disease
observed in neutropenic mice.
Although much is known regarding immune responses to
influenza in the lung far less is known regarding the effec-
tor mechanisms that control viral infection in the nose.
Whilst studies have addressed T cell responses in the
upper respiratory tract during influenza infection of mice
[44-46] the role of innate effectors in the nasal tissues is
largely unexplored. Understanding innate responses in
the upper respiratory tract is of particular importance as
the respiratory epithelium of the nasal mucosa serves as
the first susceptible site of influenza infection following
inhalation of airborne particles [47]. Clearly, neutrophils
are recruited to and accumulate in the upper airways (Fig.
1B) and play a clear role in suppressing viral growth in
nasal tissues both early (Fig. 3C) and later (Fig. 6C) in
infection. Limiting virus replication in the upper respira-
tory tract may have important consequences with regard
to subsequent transmission of infection to the lung and in
limiting viral shedding from the nasopharynx as a result
of sneezing. Recent interest regarding transmission of
avian H5N1 viruses has highlighted the importance of
understanding mechanisms that control virus growth in
the upper airways; a single amino acid substitution in the
PB2 viral protein was shown to confer avian H5N1 viruses
a growth advantage in the upper airways of mice [48] and
such a mutation was proposed to potentially provide a
platform for adaptation of avian influenza viruses to
humans and for efficient person to person transmission.
Clearly, understanding immune responses to influenza
viruses in the upper respiratory tract has never been more
important.
Studies to elucidate the role of neutrophils in murine
models of disease are complicated by the absence of a via-
ble 'knockout' mouse that specifically lacks granulocytes.
Thus, the anti-Gr-1 mAb RB6-8C5 has been used exten-
sively to characterize the function of Ly6G+ neutrophils in
murine models however there is growing evidence to sug-
gest cross-reactivity with the related Ly6C antigen on other
leukocytes, including monocytes and lymphocytes [8,26-
28]. We have used mAb RB6-8C5 to examine the effects of
neutrophil depletion in the early phase of infection using
immunocompetent B6 mice, however we have also dem-
onstrated the crucial role of neutrophils in containing the
later phases of infection and in mediating viral clearance
using B6.TAP-/-  mice. Of interest a recent report has
described the use of a Ly6G-specific mAb, 1A8, to deplete
neutrophils in the absence of direct effects on Gr-1+
monocytes [29]. While the effects of mAb 1A8 on other
leukocyte populations such as CD8+ T cells are yet to be
determined, memory-type CD8+ T cells have been shown
to express Ly6C, but not Ly6G [9]. Similarly, murine plas-
macytoid DC are reported to express Ly6C, but not Ly6G
[25,49]. Thus, use of a Ly6G-specific mAb to induce neu-
tropenia should allow a more accurate determination of
the role of granulocytes in murine models of infection in
the absence of unintended effects on other Ly-6C express-
ing leukocytes.
Conclusion
Neutrophils were recruited to the upper (nasal tissues)
and lower (lung) airways following infection of mice with
influenza virus strain HKx31. As mAb RB6-8C5 binds
directly to virus-specific CD8+ T cells, we used CD8+ T cell-
deficient mice to investigate the role of neutrophils in the
early and later phases of influenza virus infection. Neu-
trophils were shown to play a critical role in limiting virus
growth in the upper and lower respiratory tract. Further-
more, neutrophil depletion was associated with profound
weight loss and exacerbation of disease in mice infected
with a low infectious dose of HKx31. Thus, in the absenceRespiratory Research 2008, 9:57 http://respiratory-research.com/content/9/1/57
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of neutrophils, a virus strain that would normally cause
mild clinical disease was associated with severe pneumo-
nia, highlighting a critical role for these cells in contain-
ment and clearance of influenza infection.
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